$OM
Outset Medical, Inc.

2021 Q4 Form 10-Q Financial Statement

#000095017021002879 Filed on November 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $28.15M $26.32M $13.76M
YoY Change 63.23% 91.32% 423.04%
Cost Of Revenue $24.83M $23.37M $18.88M
YoY Change 47.54% 23.78% 138.29%
Gross Profit $3.321M $2.946M -$5.126M
YoY Change 696.4% -157.47% -3.17%
Gross Profit Margin 11.8% 11.19% -37.26%
Selling, General & Admin $32.71M $23.36M $26.43M
YoY Change 34.89% -11.64% 254.89%
% of Gross Profit 984.94% 792.77%
Research & Development $11.41M $9.729M $9.175M
YoY Change 46.66% 6.04% 60.74%
% of Gross Profit 343.57% 330.24%
Depreciation & Amortization $1.296M $1.313M $540.0K
YoY Change -32.85% 143.15%
% of Gross Profit 39.02% 44.57%
Operating Expenses $44.12M $33.08M $35.61M
YoY Change 37.75% -7.09% 170.65%
Operating Profit -$40.80M -$30.14M -$40.73M
YoY Change 29.06% -26.01% 120.78%
Interest Expense -$308.0K $431.0K $428.0K
YoY Change -28.37% 0.7% -59.12%
% of Operating Profit
Other Income/Expense, Net $0.00 $99.00K -$3.000K
YoY Change -3400.0% -100.53%
Pretax Income -$41.11M -$30.47M -$42.29M
YoY Change 28.3% -27.96% 174.96%
Income Tax $125.0K
% Of Pretax Income
Net Earnings -$41.23M -$30.47M -$42.29M
YoY Change 28.68% -27.96% 174.6%
Net Earnings / Revenue -146.46% -115.78% -307.46%
Basic Earnings Per Share -$0.65 -$3.44
Diluted Earnings Per Share -$945.7K -$654.0K -$3.44
COMMON SHARES
Basic Shares Outstanding 47.09M 46.59K
Diluted Shares Outstanding 46.59K

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $339.5M $373.0M $344.2M
YoY Change 7.81% 8.38%
Cash & Equivalents $182.3M $230.5M $311.3M
Short-Term Investments $157.1M $142.5M $32.90M
Other Short-Term Assets $5.529M $6.659M $4.700M
YoY Change -10.82% 41.68%
Inventory $39.19M $34.30M $11.81M
Prepaid Expenses
Receivables $25.60M $19.30M $7.082M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $409.8M $433.3M $367.8M
YoY Change 18.47% 17.8%
LONG-TERM ASSETS
Property, Plant & Equipment $12.96M $14.53M $14.41M
YoY Change -13.56% 0.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $156.0K $166.0K $1.977M
YoY Change -88.5% -91.6%
Total Long-Term Assets $53.66M $55.50M $58.20M
YoY Change -7.35% -4.63%
TOTAL ASSETS
Total Short-Term Assets $409.8M $433.3M $367.8M
Total Long-Term Assets $53.66M $55.50M $58.20M
Total Assets $463.5M $488.8M $426.0M
YoY Change 14.77% 14.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.763M $2.702M $5.062M
YoY Change -64.37% -46.62%
Accrued Expenses $39.58M $29.86M $22.40M
YoY Change 48.78% 33.31%
Deferred Revenue $6.340M $5.212M $4.132M
YoY Change 98.06% 26.14%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change
Total Short-Term Liabilities $51.70M $41.41M $33.04M
YoY Change 40.89% 25.31%
LONG-TERM LIABILITIES
Long-Term Debt $29.76M $29.74M $29.65M
YoY Change 0.3% 0.3%
Other Long-Term Liabilities $7.926M $7.908M $9.000M
YoY Change -10.94% -12.13%
Total Long-Term Liabilities $29.76M $29.74M $29.65M
YoY Change 0.3% 0.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $51.70M $41.41M $33.04M
Total Long-Term Liabilities $29.76M $29.74M $29.65M
Total Liabilities $89.38M $79.05M $71.69M
YoY Change 18.83% 10.27%
SHAREHOLDERS EQUITY
Retained Earnings -$626.0M -$584.8M -$462.0M
YoY Change 26.7% 26.58%
Common Stock $1.000B $994.5M $816.3M
YoY Change 21.59% 21.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $374.1M $409.8M $354.3M
YoY Change
Total Liabilities & Shareholders Equity $463.5M $488.8M $426.0M
YoY Change 14.77% 14.74%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$41.23M -$30.47M -$42.29M
YoY Change 28.68% -27.96% 174.6%
Depreciation, Depletion And Amortization $1.296M $1.313M $540.0K
YoY Change -32.85% 143.15%
Cash From Operating Activities -$32.68M -$28.13M -$29.12M
YoY Change 26.46% -3.4%
INVESTING ACTIVITIES
Capital Expenditures -$851.0K -$491.0K -$1.460M
YoY Change -68.01% -66.37%
Acquisitions
YoY Change
Other Investing Activities -$15.57M -$21.33M -$30.42M
YoY Change -219.56% -29.88%
Cash From Investing Activities -$16.42M -$21.82M -$31.88M
YoY Change -258.47% -31.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 934.0K 6.187M 259.8M
YoY Change -206.14% -97.62%
NET CHANGE
Cash From Operating Activities -32.68M -28.13M -29.12M
Cash From Investing Activities -16.42M -21.82M -31.88M
Cash From Financing Activities 934.0K 6.187M 259.8M
Net Change In Cash -48.16M -43.77M 198.8M
YoY Change 194.38% -122.02%
FREE CASH FLOW
Cash From Operating Activities -$32.68M -$28.13M -$29.12M
Capital Expenditures -$851.0K -$491.0K -$1.460M
Free Cash Flow -$31.83M -$27.64M -$27.66M
YoY Change 37.3% -0.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.126582
CY2021Q3 om Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
dei Entity Central Index Key
EntityCentralIndexKey
0001484612
om Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability For Conversion Of Seriesa Warrants In To Common Stock Warrants
ReclassificationOfRedeemableConvertiblePreferredStockWarrantLiabilityForConversionOfSeriesaWarrantsInToCommonStockWarrants
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
om Initial Public Offering Issuance Costs Included In Accrued Expenses
InitialPublicOfferingIssuanceCostsIncludedInAccruedExpenses
om Conversion Of Redeemable Convertible Preferred Stock In To Common Stock Upon Initial Public Offering
ConversionOfRedeemableConvertiblePreferredStockInToCommonStockUponInitialPublicOffering
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
om Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
om Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability To Additional Paid In Capital
ReclassificationOfRedeemableConvertiblePreferredStockWarrantLiabilityToAdditionalPaidInCapital
us-gaap Stock Issued1
StockIssued1
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
om Adjustment To Redemption Value On Redeemable Convertible Preferred Stock
AdjustmentToRedemptionValueOnRedeemableConvertiblePreferredStock
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
om Repayment Of Term Loan And Extinguishment Costs
RepaymentOfTermLoanAndExtinguishmentCosts
om Deemed Dividend On Settlement Of Accrued Dividend
DeemedDividendOnSettlementOfAccruedDividend
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
om Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39513
dei Entity Registrant Name
EntityRegistrantName
Outset Medical, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-0514392
dei Entity Address Address Line1
EntityAddressAddressLine1
3052 Orchard Dr.
dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95134
dei City Area Code
CityAreaCode
669
dei Local Phone Number
LocalPhoneNumber
231-8200
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
OM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Bankruptcy Proceedings Reporting Current
EntityBankruptcyProceedingsReportingCurrent
true
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47094315
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
230508000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
294972000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
142535000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
19898000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19302000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6468000
CY2021Q3 us-gaap Inventory Net
InventoryNet
34297000
CY2020Q4 us-gaap Inventory Net
InventoryNet
18384000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6659000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6189000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
433301000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
345911000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
33311000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
33311000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14532000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14998000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7494000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8253000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
166000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1356000
CY2021Q3 us-gaap Assets
Assets
488804000
CY2020Q4 us-gaap Assets
Assets
403829000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2702000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4948000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
17759000
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
16845000
CY2021Q3 om Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
11389000
CY2020Q4 om Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
7903000
CY2021Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3234000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2913000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5212000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3201000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1109000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
882000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
41405000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36692000
CY2021Q3 om Accrued Interest Noncurrent
AccruedInterestNoncurrent
600000
CY2020Q4 om Accrued Interest Noncurrent
AccruedInterestNoncurrent
240000
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
109000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
570000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7199000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8044000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29740000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29674000
CY2021Q3 us-gaap Liabilities
Liabilities
79053000
CY2020Q4 us-gaap Liabilities
Liabilities
75220000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47018000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47018000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42722000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42722000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
47000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
43000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
994486000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
822624000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000
CY2021Q3 us-gaap Gross Profit
GrossProfit
2946000
CY2020Q3 us-gaap Gross Profit
GrossProfit
-5126000
us-gaap Gross Profit
GrossProfit
4287000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13756000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74450000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32688000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23372000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18882000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
70163000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46142000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-584762000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-494059000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
409751000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
328609000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
488804000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
403829000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26318000
us-gaap Gross Profit
GrossProfit
-13454000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9729000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9175000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25331000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21066000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15726000
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13344000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
42079000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
29870000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7629000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13088000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26597000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21462000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
33084000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
35607000
us-gaap Operating Expenses
OperatingExpenses
94007000
us-gaap Operating Expenses
OperatingExpenses
72398000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-30138000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-40733000
us-gaap Operating Income Loss
OperatingIncomeLoss
-89720000
us-gaap Operating Income Loss
OperatingIncomeLoss
-85852000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
99000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
375000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
524000
CY2021Q3 us-gaap Interest Expense
InterestExpense
431000
CY2020Q3 us-gaap Interest Expense
InterestExpense
428000
us-gaap Interest Expense
InterestExpense
1284000
us-gaap Interest Expense
InterestExpense
2461000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.96
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.30
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46588000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12299000
CY2021Q3 om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-30470000
CY2020Q3 om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-42294000
om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-90703000
om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-47281000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.44
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46252000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7508000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30470000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-42294000
us-gaap Net Income Loss
NetIncomeLoss
-90703000
us-gaap Net Income Loss
NetIncomeLoss
-89449000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8000
CY2020Q3 om Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
437000
om Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
-93000
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1567000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1567000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30470000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-42294000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-90629000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-89449000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30470000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-42294000
us-gaap Net Income Loss
NetIncomeLoss
-90703000
us-gaap Net Income Loss
NetIncomeLoss
-89449000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-21000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-21000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30462000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42293000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-90724000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-89470000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
328609000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1838000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
380000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5852000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-9000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-30025000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
306645000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
149085000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1723000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3937000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-20000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-30208000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
431162000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1596000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4591000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2864000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30470000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
409751000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-372187000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
41763000
CY2020Q1 om Deemed Dividend On Settlement Of Accrued Dividend
DeemedDividendOnSettlementOfAccruedDividend
42530000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
580000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-35000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
362000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-20650000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-308347000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
80000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
683000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-26505000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-334076000
CY2020Q3 om Conversion Of Redeemable Convertible Preferred Stock Warrants To Common Stock Warrants Value
ConversionOfRedeemableConvertiblePreferredStockWarrantsToCommonStockWarrantsValue
1252000
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
456561000
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
254805000
CY2020Q3 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
3126000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1050000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13908000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-42294000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
354333000
us-gaap Net Income Loss
NetIncomeLoss
-90703000
us-gaap Net Income Loss
NetIncomeLoss
-89449000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3866000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1229000
om Non Cash Lease Expense
NonCashLeaseExpense
759000
om Non Cash Lease Expense
NonCashLeaseExpense
351000
om Non Cash Interest Expense
NonCashInterestExpense
426000
om Non Cash Interest Expense
NonCashInterestExpense
497000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1173000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-60000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
29000
om Provision For Inventories
ProvisionForInventories
766000
om Provision For Inventories
ProvisionForInventories
443000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000
om Increase Decrease In Accrued Warranty Liability
IncreaseDecreaseInAccruedWarrantyLiability
1556000
us-gaap Share Based Compensation
ShareBasedCompensation
12653000
us-gaap Share Based Compensation
ShareBasedCompensation
15171000
om Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
-93000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1567000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12838000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3197000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17925000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9236000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-718000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
5397000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2151000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
368000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
913000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3894000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3496000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
5136000
om Increase Decrease In Accrued Warranty Liability
IncreaseDecreaseInAccruedWarrantyLiability
321000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1550000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3681000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-217000
om Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-617000
om Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
241000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-97588000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-73175000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2257000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6446000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
148132000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
32884000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
24300000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
32919000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-126089000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6411000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
149085000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
255728000
om Proceeds From Issuance Of Cash Exercise Of Redeemable Convertible Preferred Stock Warrant
ProceedsFromIssuanceOfCashExerciseOfRedeemableConvertiblePreferredStockWarrant
0
om Proceeds From Issuance Of Cash Exercise Of Redeemable Convertible Preferred Stock Warrant
ProceedsFromIssuanceOfCashExerciseOfRedeemableConvertiblePreferredStockWarrant
4288000
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
126758000
om Proceeds From Stock Options Exercised And Employee Stock Purchase Plan Purchases
ProceedsFromStockOptionsExercisedAndEmployeeStockPurchasePlanPurchases
10128000
om Proceeds From Stock Options Exercised And Employee Stock Purchase Plan Purchases
ProceedsFromStockOptionsExercisedAndEmployeeStockPurchasePlanPurchases
1144000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
29630000
om Repayment Of Term Loan And Extinguishment Costs
RepaymentOfTermLoanAndExtinguishmentCosts
30985000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
8000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
159213000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
386555000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-64464000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
306969000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
328283000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37669000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
263819000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
344638000
us-gaap Income Taxes Paid
IncomeTaxesPaid
72000
us-gaap Interest Paid Net
InterestPaidNet
858000
us-gaap Interest Paid Net
InterestPaidNet
2181000
om Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
617000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
218000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
601000
om Transfer Of Inventories To Property And Equipment
TransferOfInventoriesToPropertyAndEquipment
1392000
om Transfer Of Inventories To Property And Equipment
TransferOfInventoriesToPropertyAndEquipment
1579000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8849000
om Deemed Dividend On Settlement Of Accrued Dividend
DeemedDividendOnSettlementOfAccruedDividend
42530000
om Adjustment To Redemption Value On Redeemable Convertible Preferred Stock
AdjustmentToRedemptionValueOnRedeemableConvertiblePreferredStock
362000
om Conversion Of Redeemable Convertible Preferred Stock In To Common Stock Upon Initial Public Offering
ConversionOfRedeemableConvertiblePreferredStockInToCommonStockUponInitialPublicOffering
456561000
om Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability For Conversion Of Seriesa Warrants In To Common Stock Warrants
ReclassificationOfRedeemableConvertiblePreferredStockWarrantLiabilityForConversionOfSeriesaWarrantsInToCommonStockWarrants
1252000
om Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability To Additional Paid In Capital
ReclassificationOfRedeemableConvertiblePreferredStockWarrantLiabilityToAdditionalPaidInCapital
3126000
us-gaap Stock Issued1
StockIssued1
41763000
om Initial Public Offering Issuance Costs Included In Accrued Expenses
InitialPublicOfferingIssuanceCostsIncludedInAccruedExpenses
923000
CY2020Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
254800000
CY2020Q3 om Offering Costs Underwriting Discounts And Commissions Expenses
OfferingCostsUnderwritingDiscountsAndCommissionsExpenses
23100000
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
149100000
CY2021Q2 om Offering Costs Underwriting Discounts And Commissions Expenses
OfferingCostsUnderwritingDiscountsAndCommissionsExpenses
8500000
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
In September 2020, the Company’s board of directors and shareholders approved a certificate of amendment to the amended and restated certificate of incorporation to effect a reverse split of shares of the Company’s common stock on a 7.9-for-one basis (the “Reverse Stock Split”) effective as of September 8, 2020.
us-gaap Net Income Loss
NetIncomeLoss
-90700000
us-gaap Net Income Loss
NetIncomeLoss
-89400000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-584800000
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
373000000.0
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
33300000
CY2021Q3 om Cash Cash Equivalents Restricted Cash And Short Term Investments
CashCashEquivalentsRestrictedCashAndShortTermInvestments
-406400000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
33300000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
33300000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
230508000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
311327000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
33311000
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
33311000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
263819000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
344638000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26318000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13756000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74450000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32688000
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5300000
CY2021Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q3 om Revenue Performance Obligation1
RevenuePerformanceObligation1
100000
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3000000.0
om Debt Securities Available For Sale Remaining Contractual Maturities Period
DebtSecuritiesAvailableForSaleRemainingContractualMaturitiesPeriod
one month to seventeen months
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0
CY2021Q3 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2020Q3 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
15465000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
7989000
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
7276000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
6200000
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11556000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4195000
CY2021Q3 us-gaap Inventory Net
InventoryNet
34297000
CY2020Q4 us-gaap Inventory Net
InventoryNet
18384000
CY2021Q3 om Accrued Inventory Current
AccruedInventoryCurrent
3049000
CY2020Q4 om Accrued Inventory Current
AccruedInventoryCurrent
3576000
CY2021Q3 om Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
1034000
CY2020Q4 om Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
175000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1256000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2187000
CY2021Q3 us-gaap Accrued Exchange Fee Rebate Current
AccruedExchangeFeeRebateCurrent
2420000
CY2020Q4 us-gaap Accrued Exchange Fee Rebate Current
AccruedExchangeFeeRebateCurrent
566000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3630000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1399000
CY2021Q3 om Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
11389000
CY2020Q4 om Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
7903000
CY2020Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2913000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2913000
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1702000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
5250000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
4858000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
4929000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3647000
CY2021Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3234000
CY2021Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
30000000
CY2020Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
30000000
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
260000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
326000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29740000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29674000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2864000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13908000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12653000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15171000
om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-47281000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46588000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12299000
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4343000
CY2020Q3 om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-42294000
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4810000
om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-90703000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30470000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-42294000
us-gaap Net Income Loss
NetIncomeLoss
-90703000
us-gaap Net Income Loss
NetIncomeLoss
-89449000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
362000
om Deemed Dividend On Settlement Of Accrued Dividend
DeemedDividendOnSettlementOfAccruedDividend
42530000
CY2021Q3 om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-30470000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46252000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7508000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.44
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.96
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.30
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4343000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4810000

Files In Submission

Name View Source Status
0000950170-21-002879-index-headers.html Edgar Link pending
0000950170-21-002879-index.html Edgar Link pending
0000950170-21-002879.txt Edgar Link pending
0000950170-21-002879-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
om-20210930.htm Edgar Link pending
om-20210930.xsd Edgar Link pending
om-20210930_cal.xml Edgar Link unprocessable
om-20210930_def.xml Edgar Link unprocessable
om-20210930_htm.xml Edgar Link completed
om-20210930_lab.xml Edgar Link unprocessable
om-20210930_pre.xml Edgar Link unprocessable
om-ex31_1.htm Edgar Link pending
om-ex31_2.htm Edgar Link pending
om-ex32_1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending